Baseline prepulse inhibition dependency of orexin A and REM sleep deprivation

• Published in: Psychopharmacology Vol. 241; no. 6; pp. 1213 - 1225
• Main Authors: Öz, Pınar, Kamalı, Osman, Saka, Hacer Begüm, Gör, Ceren, Uzbay, İsmail Tayfun
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2024; Springer; Springer Nature B.V
• Subjects: Age Factors; Animal models; Animals; Biomedical and Life Sciences; Biomedicine; Disease Models, Animal; Innervation; Male; Mental disorders; Neuropeptides; Neurophysiology; Neurosciences; Orexins; Orexins - administration & dosage; Orexins - metabolism; Orexins - pharmacology; Original Investigation; Pharmacology/Toxicology; Physiological aspects; Prepulse Inhibition - drug effects; Prepulse Inhibition - physiology; Psychiatry; Psychoses; Psychosis; Rats; Rats, Wistar; REM sleep; Schizophrenia; Sensorimotor gating; Sensory Gating - drug effects; Sleep and wakefulness; Sleep deprivation; Sleep Deprivation - physiopathology; Sleep, REM - drug effects; Therapeutic targets; Turkey; Psychosis; REM sleep deprivation; Orexin A; Prepulse inhibition
• ISSN: 0033-3158; 1432-2072; 1432-2072
• DOI: 10.1007/s00213-024-06555-3

Rationale Prepulse inhibition (PPI) impairment reflects sensorimotor gating problems, i.e. in schizophrenia. This study aims to enlighten the role of orexinergic regulation on PPI in a psychosis-like model. Objectives In order to understand the impact of orexinergic innervation on PPI and how it is modulated by age and baseline PPI (bPPI), chronic orexin A (OXA) injections was carried on non-sleep-deprived and sleep-deprived rats that are grouped by their bPPI. Methods bPPI measurements were carried on male Wistar rats on P45 or P90 followed by grouping into low-PPI and high-PPI rats. The rats were injected with OXA twice per day for four consecutive days starting on P49 or P94, while the control groups received saline injections. 72 h REMSD was carried on via modified multiple platform technique on P94 and either OXA or saline was injected during REMSD. PPI tests were carried out 30 min. after the last injection. Results Our previous study with acute OXA injection after REMSD without bPPI grouping revealed that low OXA doses might improve REMSD-induced PPI impairment. Our current results present three important conclusions: (1) The effect of OXA on PPI is bPPI-dependent and age-dependent. (2) The effect of REMSD is bPPI-dependent. (3) The effect of OXA on PPI after REMSD also depends on bPPI. Conclusion Orexinergic regulation of PPI response with and without REMSD can be predicted by bPPI levels. Our findings provide potential insights into the regulation of sensorimotor gating by sleep/wakefulness systems and present potential therapeutic targets for the disorders, where PPI is disturbed.